Vitamin K2 Market Growth Report | Global Outlook 2030
[Research Report] The vitamin K2 market size is projected to reach US$ 11,60,779.02 Thousands by 2030 from US$ 1,44,571.42 Thousands in 2022; the market is estimated to record a CAGR of 29.7% from 2022 to 2030.
Market Insights and Analyst View:
Vitamin K2 can affect blood clotting as well as heart and bone health. The main ones are MK-4 and MK-7. Higher intake of vitamin K2 is strongly associated with a lower risk of heart disease. It contributes to skin health and bone metabolism, as well as promotes proper brain function and prevents heart disease. In addition, vitamin K2 is important for the body's use of calcium to support bone formation and prevent calcification of blood vessels. Vitamin K2 prevents damage to blood vessels by activating the matrix GLA protein (MGP), thus inhibiting the blood vessels' calcification. Vitamin K2 deficiency, therefore, leads to un-carboxylated or inactive MGP, leading to cardiovascular disease. Another role of vitamin K2 is blood clotting. Vitamin K2 is required to synthesize specific proteins involved in blood clotting, thus preventing internal and external bleeding. Vitamin K2 is found in animal foods and canned foods. Factors such as increasing prevalence of CVD and growing cases of osteoporosis in adults and newborns are driving the vitamin K2 market growth. On the other hand, the limited awareness regarding benefits of vitamin K2 hinders the market growth.
Growth Drivers:
Increasing Prevalence of CVD Propels Vitamin K2 Market Growth
Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to the World Health Organization, CVD is a leading cause of death, registering ~17.9 million deaths every year globally. Additionally, as per the European Environment Agency, every year, more than 6 million CVD are diagnosed, and over 1.7 million people die from CVD, representing 37% of all deaths in in the European Union in 2022, making it a leading cause of death.
Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. Vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. Vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.
Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the vitamin K2 market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Vitamin K2 Market: Strategic Insights
Market Size Value in US$ 1,44,571.42 Thousands in 2022 Market Size Value by US$ 11,60,779.02 Thousands by 2030 Growth rate CAGR of 29.7% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Vitamin K2 Market: Strategic Insights
| Market Size Value in | US$ 1,44,571.42 Thousands in 2022 |
| Market Size Value by | US$ 11,60,779.02 Thousands by 2030 |
| Growth rate | CAGR of 29.7% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “vitamin K2 market” is segmented on the basis of product, dosage forms, source, application, and geography. The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Based on dosage forms, the vitamin K2 market is segmented into capsules & tablets, powder, and oils. In 2022, the powder segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Based on source, the vitamin K2 market is bifurcated into natural and synthetic. In 2022, the natural segment held a larger market share, and it is estimated to register a faster CAGR during 2022–2030. Based on application, the vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest market share, and the nutraceuticals and food segment is estimated to register the fastest CAGR during 2022–2030.
Segmental Analysis:
The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Menaquinone-7 (MK-7) is an advanced, fat-soluble form of vitamin K2 that serves multiple bodily functions. Only vitamin K2 in the form of MK-7 has been proven to provide 24-hour protection to bones and teeth from a single daily dose. MK-7 has a much longer half-life in the body and stays in the blood the longest than other forms of vitamin K2, owing to its presence not only in liver tissues but also in bones, arteries, and soft tissues. Therefore, MK-7 supplementation must only be taken once daily. According to MenaQ7, 45 mcg of MK-7 per day can increase carboxylation and activate vitamin K-dependent proteins, such as osteocalcin for bone health and Matrix GLA Protein (MGP) for heart health.
Based on dosage forms, the vitamin K2 market is segmented into capsules & tablets, powder, and oils. In 2022, the powder segment held the largest market share, and it is estimated to register the fastest CAGR during 2022–2030. Vitamin powder disintegrates quickly in water and other liquids. When taken with water, vitamin K2 products get absorbed faster in powder form and are more effective than in capsule or tablet form. High calcium level is controlled with vitamin K2 powder. Vitamin K2 helps reduce calcium absorption and lower the risk of developing kidney stones or osteoporosis. Blood-thinning drugs (anticoagulants), such as warfarin, can cause bleeding, which vitamin K2 stops and slows down. Thus, owing to such factors, the powder segment is expected to grow considerably during the forecast period.
Based on source, the vitamin K2 market is bifurcated into natural and synthetic. In 2022, the natural segment held a larger market share and is estimated to register a faster CAGR during 2022–2030. Natural vitamin K2 found in dark leafy greens is essential for metabolism and blood clotting. Vitamin K2, or menaquinone, is present in small amounts in offal and fermented foods. Gut bacteria also produce vitamin K2. Fermented foods are good vitamin K2 sources. Offal and high-fat dairy products contain significant amounts of vitamin K2 because of their fat-soluble properties. Bacteria residing in the human gut also produce small amounts of K2.
Based on application, the vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest market share, and the nutraceuticals and food segment is estimated to register the fastest CAGR during 2022–2030. The nutraceuticals and food segment is expected to grow rapidly due to high customer demand for nutritional and dietary supplements to address various nutritional deficiencies. Vitamin K2 is added as a dietary supplement in food to increase its nutritional value. Depending on the end-use direction, vitamin K2 can be consumed in food, health and dietary supplements, and functional foods. It is also found in a traditional Japanese dish called "natto." Natto is composed of fermented soybeans using different types of bacteria, including propionic acid bacteria and lactic acid bacteria.
Regional Analysis - Vitamin K2 Market:
Based on geography, the vitamin K2 market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the vK2 market. Asia Pacific is expected to register the highest CAGR in the global vK2 market during 2022–2030.
The Asia Pacific Vitamin K2 market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the vitamin K2 market in this region is widely driven by collaborations between companies, rising prevalence of cardiovascular disease (CVD), and an increasing aging population. A research article, “Cardiovascular Disease Mortality and Potential Risk Factor in China,” published in April 2022, mentioned that cardiovascular disease (CVD) is one of the serious healthcare burdens in China. In China, 290 million people suffer from coronary heart disease (11 million), cardiac disorders (13 million), heart failure (4.5), pulmonary heart disease (5 million), rheumatic heart disease (2.5 million), congenital heart disease (2 million), and hypertension (245 million). The article also states that China accounts for 40% of the total mortality related to CVD globally. Vitamin K2 plays a vital role in cardiovascular health by regulating calcium homeostasis. Vitamin K2 supplements strongly correlate with enhanced cardiovascular outcomes by modifying arterial stiffness and systemic calcification. Supported by its affordability and Food and Drug Administration (FDA)-proven safety, vitamin K2 supplements are a viable and favorable option to enhance cardiovascular outcomes. Thus, the growing burden and prevalence of CVD among the population in China is expected to increase the demand for vitamin K2 supplements, thereby boosting the market growth.
The population of China is aging faster than almost all other countries in modern history. By 2050, 39% of the total population in China will reach retirement age. As per the survey conducted by the US Census Bureau, the older population in China by 2030 will be 17.2% of the world’s total population.
With an increase in the aging population, the number of orthopedic conditions has been constantly increasing during the previous years. As per the International Osteoporosis Foundation, on average, almost 70 million Chinese above 50 years of age have osteoporosis annually. This leads to almost 687,000 fractures per year in the country. Furthermore, the estimated prevalence of osteoporosis in Mainland China is expected to be around 7% in adults, i.e., 50.1% among women above 50 years and 22.5% among men above 50 years. Vitamin K2 is essential for osteoporosis treatment and its prevention. It helps strengthen bones by activating the osteocalcin to help calcium bind to the bones. Thus, the increase in orthopedic conditions and geriatric population across the country will likely spur the demand for vitamin K2 supplements during the forecast period.
Receiving product approvals from market players further strengthens the market growth in the region. In February 2022, K2VITAL vitamin K2 MK-7 by Kappa Bioscience received approval for use in milk powders for children in China. These approvals indicate that K2 is being accepted as a mass-market ingredient and is set to expand its global footprint, notably in the early-life category. Such developments are projected to contribute to the growth of the China vitamin K2 market during the forecast period.
Vitamin K2 Market Report Scope
Industry Developments and Future Opportunities – Vitamin K2 Market:
Various initiatives taken by leading players operating in the Vitamin K2 market are listed below:
- In June 2022, Balchem Corporation announced the complete acquisition of Kappa Bioscience AS. The acquisition has helped Balchem expand its product portfolio by adding Kappa Bioscience AS's specialty vitamin K2.
- In October 2022, PLT Health Solutions, Inc. announced that non-GMO Project company offered it non-GMO verification for its menatto. In March 2022, the company introduced menatto in the US, which is manufactured by edible oils producer J-Oil Mills, Tokyo, Japan.
- In May 2023, DSM merged into Firmenich to create a robust platform for reinventing, manufacturing, and combining vital nutrients, flavors, and fragrances. The announcement was made to create a new brand called dsm-firmenich, under which the companies will have a competitive edge and growth opportunities for nutrition, health, and beauty segments.
- In April 2023, DSM announced negotiations with Adare Pharma Solutions to acquire its Adare Biome for US$ 301.2 million (€275 million). The acquisition will enable DSM to expand its human health and animal nutrition offerings.
Competitive Landscape and Key Companies - Vitamin K2 Market:
Lonza Group AG, International Flavors & Fragrances Inc, Balchem Corp., BASF SE, Lesaffre et Cie SA, Seebio Biotech (Shanghai) Co Ltd, Koninklijke DSM NV, Novozymes AS, Glanbia Plc, Anderson Global Group LLC are among the prominent vitamin K2 market companies. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Dosage Forms, Source, Application, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The vitamin K2 market is analyzed on the basis of product, dosage forms, source and applications. Based on product, the market is segmented into MK-4, MK-7 and combination products. The market is differentiated into capsules & tablets, powder and oil, on the basis of dosage forms. Based on the source of vitamin K2, the market is bifurcated into natural and synthetic vitamin K2. Based on applications, the vitamin K2 market is classified as pharmaceutical, nutraceuticals and others.
The vitamin K2 market majorly consists of the players such as Lonza Group Ag, International Flavors & Fragrances Inc., Balchem Corp., BASF SE, Lesaffre Et Cie Sa, Seebio Biotech (Shanghai) Co Ltd., Koninklijke DSM NV, Novozymes AS, Glanbia Plc., Anderson Global Group LLC.
North America region is dominating the vitamin K2 market in terms of market share and Asia Pacific is anticipated to register the highest CAGR during the forecast period.
The growth of the global vitamin K2 market is attributed to a few key factors, such as the rising prevalence of cardiovascular diseases and orthopedic disorders such as osteoporosis and bone deformities. Additionally, the rising adoption of natural health supplements and increasing awareness about the health benefits of nutraceuticals among the population is driving the growth of vitamin K2 market.
Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are the main isomers that are found to be most beneficial. Adequate intake of vitamin K2 is associated with lower risk of vascular damage because it activates matrix GLA protein (MGP) and activates osteocalcin. MGP inhibits blood vessel calcification and promotes bone formation. Natural vitamin K2 is found in fermented foods like mature cheeses and curd, and the traditional Japanese fermented soybean dish “natto.”
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Vitamin K2 Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
5. Vitamin K2 Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Prevalence of CVD
5.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
5.2 Market Restraints
5.2.1 Limited Awareness Regarding Benefits of Vitamin K2
5.3 Market Opportunities
5.3.1 Expansion of Distribution Channel
5.4 Future Trends
5.4.1 Regulatory Consideration and Standards
5.5 Impact Analysis:
6. Vitamin K2 Market - Global Market Analysis
6.1 Vitamin K2 Market Revenue (US$ Mn), 2022 – 2030
7. Global Vitamin K2 Market – Revenue and Forecast to 2030 – by Product.
7.1 Overview
7.2 Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
7.3 MK-4
7.3.1 Overview
7.3.2 MK-4: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
7.4 MK-7
7.4.1 Overview
7.4.2 MK-7: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Combination Drugs
7.5.1 Overview
7.5.2 Combination Drugs: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Vitamin K2 Market – Revenue and Forecast to 2030 – by Dosage Form.
8.1 Overview
8.2 Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
8.3 Capsules and Tablets
8.3.1 Overview
8.3.2 Capsules and Tablets: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Powder
8.4.1 Overview
8.4.2 Powder: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oil
8.5.1 Overview
8.5.2 Oil: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Vitamin K2 Market – Revenue and Forecast to 2030 – by Source.
9.1 Overview
9.2 Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
9.3 Natural
9.3.1 Overview
9.3.2 Natural: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Synthetic
9.4.1 Overview
9.4.2 Synthetic: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Vitamin K2 Market – Revenue and Forecast to 2030 – by Application.
10.1 Overview
10.2 Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
10.3 Pharmaceuticals
10.3.1 Overview
10.3.2 Pharmaceuticals: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Nutraceuticals and Food
10.4.1 Overview
10.4.2 Nutraceuticals and Food: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11. Vitamin K2 Market - Geographical Analysis
11.1 North America: Vitamin K2 Market
11.1.1 Overview
11.1.2 North America: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.1.4 North America: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.1.5 North America: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.1.6 North America: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.1.7 North America: North America, by Country, 2022 & 2030 (%)
11.1.7.1 US: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.1.7.1.4 US: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.1.7.1.5 US: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.1.7.1.6 US: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.1.7.2 Canada: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.1.7.3 Mexico: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.2 Europe Vitamin K2 Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Vitamin K2 Market, by Product
11.2.4 Europe Vitamin K2 Market, by Dosage Form
11.2.5 Europe Vitamin K2 Market, by Source
11.2.6 Europe Vitamin K2 Market, by Application
11.2.7 Europe Vitamin K2 Market by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.1.3 Germany Vitamin K2 Market, by Product
11.2.7.1.4 Germany Vitamin K2 Market, by Dosage Form
11.2.7.1.5 Germany Vitamin K2 Market, by Source
11.2.7.1.6 Germany Vitamin K2 Market, by Application
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK Vitamin K2 Market, by Product
11.2.7.2.4 UK Vitamin K2 Market, by Dosage Form
11.2.7.2.5 UK Vitamin K2 Market, by Source
11.2.7.2.6 UK Vitamin K2 Market, by Application
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France Vitamin K2 Market, by Product
11.2.7.3.4 France Vitamin K2 Market, by Dosage Form
11.2.7.3.5 France Vitamin K2 Market, by Source
11.2.7.3.6 France Vitamin K2 Market, by Application
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.4.3 Italy Vitamin K2 Market, by Product
11.2.7.4.4 Italy Vitamin K2 Market, by Dosage Form
11.2.7.4.5 Italy Vitamin K2 Market, by Source
11.2.7.4.6 Italy Vitamin K2 Market, by Application
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain Vitamin K2 Market, by Product
11.2.7.5.4 Spain Vitamin K2 Market, by Dosage Form
11.2.7.5.5 Spain Vitamin K2 Market, by Source
11.2.7.5.6 Spain Vitamin K2 Market, by Application
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe Vitamin K2 Market, by Product
11.2.7.6.4 Rest of Europe Vitamin K2 Market, by Dosage Form
11.2.7.6.5 Rest of Europe Vitamin K2 Market, by Source
11.2.7.6.6 Rest of Europe Vitamin K2 Market, by Application
11.3 Asia Pacific: Vitamin K2 Market
11.3.1 Overview
11.3.2 Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
11.3.7.1 China: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.1.4 China: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.1.5 China: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.1.6 China: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7.2 Japan: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7.3 India: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.3.4 India: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.3.5 India: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.3.6 India: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7.4 Australia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.4.4 Australia Pacific Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.4.5 Australia Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.4.6 Australia Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7.5 South Korea: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.4 Middle East and Africa: Vitamin K2 Market
11.4.1 Overview
11.4.2 Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East and Africa: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.4.4 Middle East and Africa: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.4.5 Middle East and Africa: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.4.6 Middle East and Africa: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.4.7 Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
11.4.7.1 South Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.4.7.3 U.A.E: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 U.A.E: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 U.A.E: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.4.7.3.4 U.A.E: Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.4.7.3.5 U.A.E: Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.4.7.3.6 U.A.E: Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East and Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Vitamin K2 Market, by Product, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa Vitamin K2 Market, by Source, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East and Africa Vitamin K2 Market, by Application, 2020–2030 (US$ Million)
11.5 South & Central America Vitamin K2 Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Vitamin K2 Market, by Product
11.5.4 South & Central America Vitamin K2 Market, by Dosage Form
11.5.5 South & Central America Vitamin K2 Market, by Source
11.5.6 South & Central America Vitamin K2 Market, by Application
11.5.7 South & Central America Vitamin K2 Market by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.1.3 Brazil Vitamin K2 Market, by Product
11.5.7.1.4 Brazil Vitamin K2 Market, by Dosage Form
11.5.7.1.5 Brazil Vitamin K2 Market, by End-User
11.5.7.1.6 Brazil Vitamin K2 Market, by Application
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina Vitamin K2 Market, by Product
11.5.7.2.4 Argentina Vitamin K2 Market, by Dosage Form
11.5.7.2.5 Argentina Vitamin K2 Market, by End-User
11.5.7.2.6 Argentina Vitamin K2 Market, by Application
11.5.7.3 Rest of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest of South & Central America Vitamin K2 Market, by Product
11.5.7.3.4 Rest of South & Central America Vitamin K2 Market, by Dosage Form
11.5.7.3.5 Rest of South & Central America Vitamin K2 Market, by End-User
11.5.7.3.6 Rest of South & Central America Vitamin K2 Market, by Application
12. Vitamin K2 Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in Vitamin K2 Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Lonza Group AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 International Flavors & Fragrances Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Balchem Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BASF SE
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lesaffre et Cie SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Seebio Biotech (Shanghai) Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Koninklijke DSM NV
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novozymes AS
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Glanbia Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Anderson Global Group LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Vitamin K2 Market Segmentation
Table 2. North America Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 8. US Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 9. US Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 19. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Surgery
Table 20. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Source
Table 21. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) – Application
Table 22. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 23. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 24. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 25. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 26. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 27. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 28. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 29. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 30. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 31. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 32. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 35. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 36. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 37. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 38. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 39. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 40. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 41. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 42. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 43. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 44. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 45. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 46. Asia Pacific Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 50. China Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. China Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 52. China Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 53. China Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 54. Japan Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 58. India Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 59. India Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 60. India Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 61. India Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 62. Australia Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 66. South Korea Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Asia Pacific Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 74. Middle East and Africa Vitamin K2 Market, by Product– Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East and Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East and Africa Vitamin K2 Market, by Source – Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East and Africa Vitamin K2 Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 78. South Africa Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 81. South Africa Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 82. Saudi Arabia Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 85. Saudi Arabia Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 86. U.A.E Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. U.A.E Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 88. U.A.E Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 89. U.A.E Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Middle East and Africa Vitamin K2 Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form– Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East and Africa Vitamin K2 Market, by Source– Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East and Africa Vitamin K2 Market, by Application– Revenue and Forecast to 2030 (US$ Million)
Table 94. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 95. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Surgery
Table 96. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Source
Table 97. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 98. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 99. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 100. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 101. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 102. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 103. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 104. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 105. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 106. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 107. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Surgery
Table 108. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 109. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 110. Recent Organic Growth Strategies in Vitamin K2 Market
Table 111. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 112. Glossary of Terms, Vitamin K2 Market
List of Figures
Figure 1. Vitamin K2 Market Segmentation, By Geography
Figure 2. North America - PEST Analysis
Figure 3. Vitamin K2 Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Vitamin K2 Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. MK-4: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. MK-7: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Combination Drugs: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 11. Capsules and Tablets: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Powder: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oil: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 15. Natural: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Synthetic: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 18. Pharmaceuticals: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Nutraceuticals and Food: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: North America, by Country, 2022 & 2030 (%)
Figure 24. US: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Canada: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Mexico: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe Vitamin K2 Market, By Geography, 2022 ($Mn)
Figure 28. Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
Figure 30. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 31. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 32. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Asia Pacific: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
Figure 40. China: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Japan: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. India: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Australia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. South Korea: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Rest of Asia Pacific: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Middle East and Africa: Vitamin K2 Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Middle East and Africa Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
Figure 49. South Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Saudi Arabia: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. U.A.E: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Rest of Middle East and Africa: Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Vitamin K2 Market, By Geography, 2022 ($Mn)
Figure 54. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Vitamin K2 Market, By Key Countries, 2022 and 2030 (%)
Figure 56. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Growth Strategies in Vitamin K2 Market
The List of Companies - Vitamin K2 Market
- Lonza Group Ag
- International Flavors & Fragrances Inc
- Balchem Corp
- BASF SE
- Lesaffre Et Cie Sa
- Seebio Biotech (Shanghai) Co Ltd
- Koninklijke DSM NV
- Novozymes As
- Glanbia Plc
- Anderson Global Group LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For